Monocytes could be a bridge from inflammation to thrombosis on COVID-19 injury: A case report-Reference-Cited by-同舟云学术

Monocytes could be a bridge from inflammation to thrombosis on COVID-19 injury: A case report

Published:2020-12 Issue: Volume:1 Page:100007
ISSN:2666-5727
Container-title:Thrombosis Update
language:en
Short-container-title:Thrombosis Update

Author:

Mazzone Antonino,Castelnovo Laura^ORCID,Tamburello Antonio,Gatti Arianna,Brando Bruno,Faggioli Paola,Mumoli Nicola^ORCID

Publisher

Elsevier BV

Reference7 articles.

1. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up;Bikdeli;J. Am. Coll. Cardiol.,2020

2. C-reactive protein increase in unstable coronary disease cause or effect?;De Servi;J. Am. Coll. Cardiol.,2005

3. Prevention of pulmonary injury in isolated perfused rat lungs by activated human neutrophils preincubated with anti-Mo1 monoclonal antibody;Ismail;Blood,1987

4. Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease;Mazzone;Circulation,1993

5. Increased expression of CD11b/CD18 on phagocytes in ischaemic disease: a bridge between inflammation and coagulation;Mazzone;Eur. J. Clin. Invest.,1997

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pronounced benefits of JAK inhibition with baricitinib in COVID-19 pneumonia in obese but not lean subjects;RMD Open;2024-05

2. Immunotherapy of COVID-19: Inside and Beyond IL-6 Signalling;Frontiers in Immunology;2022-02-22

3. Unraveling the molecular crosstalk between Atherosclerosis and COVID-19 comorbidity;Computers in Biology and Medicine;2021-07

4. Iloprost in COVID-19: The Rationale of Therapeutic Benefit;Frontiers in Cardiovascular Medicine;2021-04-23

5. The internist during the COVID-19 pandemic;Italian Journal of Medicine;2020-12-22